Emily Gardel focuses her practice on patent prosecution in areas where electronic devices and software overlap with biotechnology. She has worked with technologies related to single molecule detection, imaging systems, medical devices, microfluidics, biosensors, diagnostic devices and software, bioinformatics, and data processing, including technologies implementing machine learning.
Emily works with start-ups, midsize firms, and large multi-national companies, as well as several academic institutions. She has extensive experience handling prosecution matters in the biological-electrical-computational space, advising clients on all aspects of IP strategy and portfolio development both in the United States and abroad. Emily also advises clients on related issues beyond patent prosecution, including due diligence and freedom-to-operate.
Emily’s graduate research on microbial extracellular electron transfer at Harvard involved designing bioelectrochemical systems, culturing microorganisms, using optical and electron microscopy in combination with sample preparation and image analysis techniques, analyzing genomic sequence data. Emily has also performed research on force generation in two- and three-dimensional granular flow materials and methods to remove aberrations from optical traps.
Emily is interested in increasing diversity in tech and among inventors, and participates in mentoring programs and events through organizations that focus on improving representation of minority groups in STEM fields.